Recombinant human tissue-type plasminogen activator derivative (Shanghai Fudan-Zhangjiang/Shandong Ahua)
重组人组织型纤溶酶原激酶衍生物（上海复旦张江生物医药/山东阿华生物药业）
Report date: 2026/05/21 20:00:22
Base Information
Drug NameRecombinant human tissue-type plasminogen activator derivative (Shanghai Fudan-Zhangjiang/Shandong Ahua)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2007/09/30
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesChina Resources Angde Biotech Pharma Co Ltd
Inactive CompaniesAngde Biotech Pharmaceutical Co Ltd
Active Indications +[4]
Inactive Indications
Other Information
ATC Code
Related LinksN/A